GlassScriptPhysician profile
Prodromos G Borboroglu
NPI 1770543894
$1,849.52
in general payments reported to CMS, 2019-2025
10 companies · $67.75 in 2025
The $67.75 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $80.51 · 2020: $16.95 · 2021: $20.66 · 2022: $13.26 · 2023: $48.51 · 2024: $1,602 · 2025: $67.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $1,500 · Food and Beverage: $218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $1,500.00 |
| Food and Beverage | $218.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $1,500.00 | 2024 | Visera Elite II Video System Center |
| Medtronic, INC. | $107.67 | 2022-2025 | Interstim |
| Astellas Pharma US INC | $84.35 | 2019-2023 | Myrbetriq |
| Axonics, INC. | $45.21 | 2021-2024 | Axonics |
| Coloplast Corp | $28.85 | 2023-2025 | Titan |
| Boston Scientific Corporation | $18.72 | 2025 | Axonics |
| Cook Medical LLC | $18.30 | 2025 | Litho 150 |
| Karl Storz Endoscopy-America | $16.95 | 2020 | |
| Teleflex LLC | $16.41 | 2023 | Urolift |
| Janssen Biotech, INC. | $13.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prodromos Borboroglu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.